Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00353587
Status:
COMPLETED
Last Update Posted:
2015-05-01
First Post:
2006-07-14
Brief Title:
Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin
Sponsor:
CymaBay Therapeutics Inc
Organization:
CymaBay Therapeutics Inc
Organization Data
Organization:
CymaBay Therapeutics Inc
Class:
INDUSTRY
Study ID:
M102-20509
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CymaBay Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None